InvestorsHub Logo
Followers 33
Posts 2837
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Thursday, 11/04/2021 2:57:49 PM

Thursday, November 04, 2021 2:57:49 PM

Post# of 151
ASH abstract (TIP)

A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies https://ash.confex.com/ash/2021/webprogram/Paper146602.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News